Phase 3 TRIUMPH Program: The Newest Evidence In December 2025, Eli Lilly released the first Phase 3 results from the TRIUMPH clinical development program
Taurine injections can be used to help reduce inflammation, lower blood pressure, support cardiovascular health, reduce symptoms associated with metabolic syndrome by improving insulin resistance, regulate glucose metabolism and lower cholesterol
Cardiovascular Benefits Across the BMI Spectrum The cardiovascular benefits of semaglutide were independent of baseline adiposity measures, meaning patients across the full spectrum of BMI values experienced similar relative risk reductions
The TGA said since this study it conducted its own independent assessment of the potential association between GLP-1 RAs and NAION and sought advice from the Advisory Committee on Medicines
You might see weight stabilize or even continue increasing slightly during the initial restart period
Because of this, its recommended that anyone starting treatment be screened for existing mental health conditions and closely monitored for changes in mood or behavior over time